DATA SHEET

AMBULATORY BLOOD PRESSURE MONITORING

It’s long been known that high blood pressure can lead to cardiovascular disease. Now, regulators are looking for a connection between blood pressure and cardiovascular events during drug therapy. As a result, new FDA draft guidance advises sponsors to assess a drug’s effect on blood pressure.

The best and most patient-friendly way to collect blood pressure data during a clinical trial is ambulatory blood pressure monitoring or ABPM. Read on to learn more about implementing ABPM and its benefits for patients, sites, and sponsors.


DataSheet - Cardiac Safety - Ambulatory Blood Pressure Monitoring